CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Pharmacelera aims to enhance the drug development process by creating an open machine learning platform for Computer-Aided Drug Design. This platform will improve the accuracy of molecular property predictions, significantly reducing the failure rates of drug candidates and overall development costs.
The competitiveness of the R&D process in this industry has been steadily declining during the past two decades.
Whereas in 2000 the average cost for developing a new drug was close to €1 billion, in 2015 the estimated cost was €2.58 billion, a 150% increase.
Consequently, the different actors of the pharmaceutical R&D industry have an urgent need to improve their effectiveness to develop new drugs.
In this sense, the early stage of the R&D process shows the greatest potential to increase the su…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
